Alkem Laboratories Limited — Financials & Forensics
Sector: Healthcare · NSE: ALKEM · BSE: 539523 · ISIN: INE540L01014
07 Sep 2026
Add ALKEM to your watchlist — all of this, automated.
Sign in with GoogleAnnual P&L snapshot
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue from operations | ₹10,634 Cr | ₹11,599 Cr | ₹12,668 Cr | ₹12,965 Cr | ₹14,712 Cr |
| EBITDA | ₹2,053 Cr | ₹1,609 Cr | ₹2,245 Cr | ₹2,512 Cr | ₹3,005 Cr |
| EBITDA margin | 19.3% | 13.9% | 17.7% | 19.4% | 20.4% |
| Profit after tax | ₹1,680 Cr | ₹1,007 Cr | ₹1,811 Cr | ₹2,165 Cr | ₹2,302 Cr |
Deeper analysis
Recent filings by Alkem Laboratories Limited
-
Please find attached herewith Proceedings of the meeting of the equity shareholders of the Company a
17 Aug 2026 · Corporate Action
-
Please find attached herewith intimation for a copy of newspaper publication
15 Aug 2026 · Regulatory Compliance
-
Analysts/Institutional Investor Meet/Con. Call Updates
14 Aug 2026 · General Update
-
The Financials Results of the Company for the quarter ended 30th June, 2026 having been communicated
14 Aug 2026 · Regulatory Compliance
-
Pl find attached herewith intimation under Reg 30
14 Aug 2026 · Corporate Action
Never miss a filing again
About Alkem Laboratories Limited on Indian Stock Alerts
Indian Stock Alerts tracks Alkem Laboratories Limited's SEBI / exchange filings in real time. Every quarterly result, audited annual report, shareholding pattern update, insider trade and corporate announcement is automatically parsed and surfaced as a structured data point — with a link back to the underlying filing.
Data points refreshed daily include closing price, 1Y change, market cap, P/E, ROE, dividend yield, RPT volume, audit / governance / accrual flags. Quarterly results numbers refresh within minutes of the company filing them with BSE / NSE.